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ABSTRACT  Statin,  a  57,000-D  protein  characteristically  found  in  nonreplicating  cells,  was 
identified by a monoclonal antibody produced by hybridomas established  from mice injected 
with extracts  of in vitro aged  human fibroblasts (Wang,  E.,  1985, J.  Cell Biol.,  100:545-551). 
Fluorescence staining with the antibody shows that the expression  of statin disappears  upon 
reinitiation of the process for cell replication. The rapid de-expression is observed in fibroblasts 
involved in the in vitro wound-healing process, as well as in cells that have been subcultured 
after trypsinization and replated from a confluent culture. Kinetic analysis shows that 50% of 
the cell population lose their statin expression  at 12 h after replating,  before the actual events 
of mitosis.  Immunogold  labeling with  highly purified  antibodies  localizes  the protein at the 
nuclear envelope  in  nonreplicating cells,  but not in their replicating counterparts.  Immuno- 
blotting analysis confirms the disappearance of statin  in cells that have reentered the cycling 
process. Using the technique of flow cytometry to examine the large number of nonreplicating 
fibroblasts in confluent cultures, we have found that statin is mostly expressed  in those cells 
showing the least amount of DNA content, whose growth is blocked at the G0/G~ stage of the 
cell  cycle.  This  close  correlation  is  rapidly  altered  once  the  cells  are  released  from  the 
confluent state. These results suggest that the expression  of statin may be regulated by a fine 
mechanism controlling the transition from the nonreplicating to the replicating state, and that 
the protein is structurally associated with the nuclear envelope. 
Studies to distinguish proliferating cells from their nonprolif- 
erating counterparts were limited to a description of pheno- 
typic characteristics until the recent development of powerful 
probes,  such  as  cDNA  clones  and  monoclonal  antibodies. 
Lately, a growing number of new proteins have been identified 
in cells at particular stages of development or differentiation 
by the use of unique monoclonal antibodies (3, 7, 8). With a 
similar approach, several novel proteins found only in prolif- 
erating or in nonproliferating cells have been localized either 
on the cell surface or in the nucleus (2, 6,  11). 
We reported earlier that a protein of 57,000 D is present in 
the nucleus of nonproliferating cells from several lines of in 
vitro aged human  fibroblasts, but not  in  their proliferating 
counterparts (11).  However, the presence of this nuclear an- 
tigen was not restricted to senescent fibroblasts; young fibro- 
blasts can be induced to express it upon the arrest of prolif- 
eration such as culturing to confluency. The nuclear presence 
of this  protein  also  is  characteristic  of  many  tissue  sites 
composed of nonproliferating cells (12).  The absence of this 
protein is noted in tissues,  such as epithelium of the gastroin- 
testinal tract and kidney and the basal layer of the epidermis, 
where ceils are replicating. 
We now report that the expression of statin can be rapidly 
turned off once the restriction of cell replication at Go/G~ is 
removed. The deactivation of statin expression is heteroge- 
neous among different cells but, in general, occurs before the 
actual  event of mitosis. Therefore, the  expression  of statin 
seems to be incompatible with the mechanism that promotes 
cell cycling events. 
MATERIALS  AND  METHODS 
Cultures  of Human  Fibroblasts 
Two  cell strains of human  fibroblasts were  obtained  from  the  Human 
Genetic Cell Repository (Camden,  N J).  These cell strains were initiated by 
Abbreviation used in this paper. PDLs, population doubling levels. 
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0011 was designated for the fibroblast cultures derived from a donor of 8 fetal 
wk, and 3529 for cultures derived from another donor 66-yr-old. The complete 
in vitro life spans of  these two cell strains have been established in our laboratory 
and reported  ( 11 ). Cultures of varied life spans as represented by population 
doubling  levels (PDLs) ~ were acquired  by serial passage as described (4,  11). 
Eagle's minimum essential medium supplemented  with  10%  fetal calf serum 
and  1%  nonessential  amino acid  was used  for growth  and  maintenance  of 
cultures at 37"C with humidified air and 5% CO2. 
Antibodies 
A mouse hybridoma clone S-30 was identified to produce an antibody that 
detects a protein  of 57,000 D present  in abundance  only in nonproliferating 
cells. This hybridoma clone was established by injecting a mouse with insoluble 
cellular materials derived from the senescent fibroblasts of the 3529 cell strain. 
A detailed description  of the antigenic  activity was reported  previously (11). 
The quality of monoclonal antibody was improved by generating a serum-free 
supernatant of clone S-30 cultures. After precipitation with ammonium sulfate, 
the secreted immunoglobulin (IgG) was concentrated  100-fold and used as the 
stock solution for various immunoassays  of the present study. 
Reinitiation of Proliferating Activity 
IN  VITRO WOUNDING  EXPERIMENTS:  Young fibroblasts with high 
replicating activity at an early stage of  their life span were grown into confluency 
to halt the activity of proliferation.  Growing cultures of both 3529 and 0011 
cell strains at PDLs less than 15 were used. Cultures were initiated at a density 
of 3,550 cells/cm 2, and confluency was reached as cells grew to ten times this 
density  ~7 d  after initial  plating.  These cultures  were kept  in this confluent 
state  for  another  3 d  before  use. The absence  of proliferating  activity  was 
monitored  by time-lapse cinematography  showing little mitotic  activity, and 
by quantitation  of DNA content by flow cytometry (see below). Denudation  of 
an area of -2 × 4 cm  2 was introduced  into these confluent cultures by sterile 
razor blades. 
TRYPSINIZATION  AND  REPLATING:  The same  type  of confluent 
culture  as described  above  was  used  for  reinitiation  of cell replication  by 
subculturing  at lower growth density. Cells were dislodged from the confluent 
monolayer  by treatment with trypsin  at 0.5%, and replated  into the  growth 
medium at a density of 1,770 cells/cm 2. Mitosis was reinitiated and examined 
by kinetic studies at various time intervals after the seeding of the fibroblasts. 
Time-Lapse Cinematography 
The mitotic frequency in cultures of nonreplieating cells, as well as fibroblasts 
with reinitiated replicating activity, was investigated by cinematographic studies 
using a time-lapse video recording device. Cultures were filmed directly on a 
Nikon Diaphot inverted microscope with 6x phase optics (Nikon Inc., Garden 
City, NY). The temperature  of the environment immediately surrounding the 
culture was maintained  at 37"C by a Sage air incubator (Sage Instruments Div., 
Cambridge, MA). Cell locomotion  as well as the actual events of cell division 
were  recorded  on  Beta-max  videotape  by  a  National  Electrostatics  Corp. 
(Middleton,  WI) time-lapse  videotape  recorder.  The recorded  tape  was then 
analyzed on a regular Audiotronics  monitor (Audiotronic,  Inc., North Holly- 
wood, CA). Experiments for cinematographic  studies were designed in parallel 
to those cell specimens used for various immunoassays. These parallel experi- 
ments allow us to compare the expression of statin in various cell cultures with 
mitotic frequency. 
Immunofluorescence and 
Immunoelectron Microscopy 
Presence of statin  was identified at the light microscopic level by labeling 
the  formaldehyde-fixed and acetone-extracted  cell specimens with the  mouse 
monoclonal  antibody,  S-30. Fluoresceinated  secondary  antibody,  goat anti- 
mouse immunoglobulin,  was used to localize the binding  sites of S-30 lgGs. 
The details of the labeling procedure  have been reported (l 1). To identify the 
ultrastructural  location  of S-30 binding  sites, we have used the technique  of 
immunogold labeling (5), In brief, cell specimens were prepared by formalde- 
hyde fixation, followed by extraction  with 0.5% Triton  in phosphate-buffered 
saline (PBS), at pH 7.2. These specimens were then labeled with the antibody 
to statin,  followed by labeling with protein  A conjugated with 5-nm colloidal 
gold particles  as described (14). Afterwards, the samples were processed for 
routine electron microscopy (13). 
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Immunoblotting  Analysis 
Fibroblasts of confluent cultures of the 0011 strain as described above were 
processed to obtain  cellular materials of nonreplicating  cells. Cells were har- 
vested in PBS and pelleted by low speed centrifugation ( 1,000 rpm for 10 min). 
The cell pellets were then homogenized and lysed with a dounce homogenizer 
in lysis buffer containing  20 mM Tris,  10 mM KCI, 5 mM MgCI2, 0.1  mM 
phenylmethylsulfonyl fluoride, 4 mM EDTA, and 2 mM EGTA. The cell lysate 
was treated with deoxyribonuclease I (DNase I) for 30 min at 4"C to remove 
the  DNA,  followed by tip-sonication  to dissociate the insoluble cytoskeletal 
materials.  Cellular  proteins  were then separated  electrophoretically  on  10% 
polyacrylamide gels. Replicating fibroblasts of a sparse culture, with only 2% 
of cells showing staining activity for statin, were processed in the same fashion 
for  gel  electrophoresis.  The  same  amount  of protein  specimens  for  both 
nonreplicating  and  replicating  fibroblasts were used  for gel  electrophoresis. 
Proteins were then transferred to nitrocellulose paper in a Hoefer Trans-blot 
chamber (Hoefer Scientific Instruments,  San Francisco, CA), as described (9). 
Normal  goat  serum  at  0.05 ug/ml was used to remove  nonspecific activity 
before incubation  overnight with the primary S-30 antibody at  1:500 dilution 
in  PBS containing  0.03% Tween-20. The second  antibody  was peroxidase- 
conjugated goat anti-mouse lgG (HyClone Laboratories, Logan, UT) at 0.04 
ug/ml for incubation at room temperature  for 1 h. The detailed procedure has 
been reported (10). 
Simultaneous Examination of Cell Cycle  Analysis 
and Statin Expression 
The  newly developed  technique  of flow cytometry  was used to examine 
statin expression via antibody staining and the distribution  of cell cycle phases 
by DNA content (1). The detailed procedure of simultaneous measurements of 
DNA quantity  and the  fluorescent intensity  for antibody  labeling of cellular 
antigens was recently described (15). In brief, the DNA content was measured 
by staining intensity with propidium  iodide, which can be detected by a band 
of 600-650-nm  wavelength  for  red  fluorescence.  The  statin  expression  is 
measured by the band of 515-575-nm  wavelength to detect the green fluores- 
cence of fluorescein isothiocyanate-labeled  secondary antibody. A third  para- 
meter, red pulse width determined by nuclear diameter, was used to discrimi- 
nate single cells from cell aggregates. Cells were initially prepared for indirect 
immunofluorescence  microscopy, and after treatment  with RNase were coun- 
terstained with propidium iodide for DNA content. The measurements ofstatin 
expression and cell cycle distribution  were performed  on the  Cytofluorograf 
FC200  (Ortho  Diagnostic  Instruments,  Westwood,  MA) with  the  generous 
assistance  of the  laboratory  of Dr.  Andreeff  of Memorial  Sloan-Kettering 
Cancer Center, New York. 
RESULTS 
In vitro wounding was the  first  approach to  reinitiate  cell 
cycling activity in confluent cultures of nonreplicating fibro- 
blasts.  In general,  a  time span  of 6  h  was needed  for the 
culture to recover from the mechanical shock incurred during 
the wounding. Subsequently, cells migrated into the wounded 
area by  forming fan-shaped  leading  edges.  Fig.  1A  shows 
locomotion activity of migrating fibroblasts of the 0011  cell 
strain  at  12  h  after the  initiation  of the  wound.  A  layer 
consisting  of cells that  have  moved away  from the  dense 
region of the confluent monolayer sheet has already formed 
at the edge of the wound. Staining of this cell specimen with 
S-30  antibody  shows  that  these  cells  are  negative  for the 
presence of statin, whereas those cells remaining in the con- 
fluent region show positive staining for the antibody. While 
most of these cells display rigorous motility and have broken 
away from contact with the neighboring cells, mitotic activity 
is not  yet observed.  Results of time-lapse cinematographic 
studies show that a high frequency of mitosis was not noticed 
until 24 h  after the establishment of the wound. Figs.  1,  C 
and  D  demonstrates a  similar phenomenon  of the  loss of 
statin in the locomoting cells of the 3529 cell strain. 
A second approach to reinitiate replicating activity involved 
passing  the  confluent  cultures  to  lower  cell  density.  The FIGURE  1  The disappearance of statin-associated nuclear staining in cells (arrowheads) that have migrated from dense cultures 
to wound regions. A denuded area was introduced by mechanical wounding at the area indicated by the dotted lines. 12 h after 
the establishment  of the wound, fibroblasts  had already migrated  into the open area and  lost their nuclear staining  activity. 
However, the statin staining activity was still detectable in the nuclei of those cells that remained in the dense area, whose growth 
continued to be arrested by contact with the neighboring  cells. (A and B) Cultures of human fibroblasts (0011 cell strain) derived 
from a donor of 8 fetal wk were maintained at high density (35,550 cells/cm 2) at early stages of life with PDLs of 12. (C and D) 
Cultures  of human fibroblasts  (3529 cell strain) derived from a donor 66-yr-old were maintained at the same density with PDLs 
of 14. Identical cell specimens were visualized by phase contrast (A and C) and fluorescence  (B and D) optics to show relative 
positioning of each cell in the cultures,  x  450. 
mitogenic effect via trypsinization and replating into a  less 
crowded environment allows the cells to reenter the process 
of cycling. Figs. 2, A and B demonstrates that most cells still 
exhibit the statin-positive phenotype during the initial 4-6 h 
after subculturing. Not until 12 h after replating is the statin- 
negative phenotype observed in recognizable frequency (Figs. 
2, C and D). This heterogeneous expression of  statin continues 
in  culture for another  12  h,  with an  increasing number of 
cells showing the negative phenotype (Figs. 2, E  and F). At 
24 h after replating, close to 90% of  the cell monolayer shows 
negative staining activity for antibody to statin (Figs. 2, G and 
H). Time-lapse cinematographic studies show that the culture 
at this point begins to show noticeable mitotic activity. 
Quantitation of the statin loss in post-trypsinized cultures 
was made by direct examination of fluorescent staining activ- 
ity,  counting  ~500  cells  of the  specimens;  the  results  are 
shown  in  Fig.  3.  For the  initial  4  h  after release from the 
contact arrest of growth, >80% of the cells still retain statin 
expression. At  12 h, the loss of statin expression reaches to 
50% of the cell cultures. At 24 h, the loss of nuclear staining 
reaches its peak  as  -80%  of the  flbroblasts show  negative 
antigenic reaction to statin. 
Immunogold labeling with high-titred antibody showed that 
statin is primarily located at the nuclear envelope in nonpro- 
liferating fibroblasts of confluent cultures (Fig. 4 a). Statin is 
distributed along the entire nuclear envelope, as indicated by 
the positioning of gold particles. A  few gold particles were 
seen  associated  with  the  nucleoplasm  as  well  as  adjacent 
intermediate filaments on the cytoplasmic side.  This is pos- 
sibly due to nonspecific background staining, since the same 
type of  gold labeling was observed in control specimens when 
the primary antibody was replaced with a  monoclonal anti- 
body  to  neurofilaments  (which  are  not  found  in  human 
flbroblasts).  As  shown  in  Fig.  4b,  the  nuclear  envelope- 
specific labeling was not observed when anti-statin IgGs were 
incubated with replicating fibroblasts, when the restriction of 
growth by confluency was removed. 
To determine that the absence of nuclear staining seen by 
fluorescence microscopy is indeed the absence of statin, we 
have subjected the insoluble protein extracts from the non- 
replicating fibroblasts of the confluent cultures to gel electro- 
phoresis, followed by transfer to nitrocellulose paper. When 
the paper was incubated with S-30 monoclonal antibody, the 
57,000-D  protein  and  the  accompanying  high  molecular 
WANG  Rapid De-expression of Statin in Cycling Fibroblasts  1697 FIGURE  2  Rapid  disappearance of statin  expression in  cells  whose  replicating activity was reinitiated by  trypsinization and 
replating as described in Materials and Methods. Kinetic studies  using immunofluorescence microscopy showed the heteroge- 
neous loss of statin  in cultures at 4  h  (A and B),  12  h (C and D),  16 h (E and  F), and 24  h (G and H) after trypsinization and 
replating. During the initial hours,  most cells remained statin-positive (A and B). More than 50% of cells displayed the negative 
phenotype at 12 h after subculturing (C and D).  By 24 h, >85% of cells lost their statin expression (G and H). Phase contrast (A, 
C,  E, and  G) and fluorescence (B,  D,  F, and  H)  images of the same cell specimens are  presented to show the statin-negative 
(arrowheads) and the statin-positive cells. Confluent cultures of 0011 cell strain as described for Fig. 1, A and B PDLs of 12 were 
used for trypsinization and subculturing, x  550. 
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FIGURE  3  Kinetic  studies  of  statin  disappearance in  cells  after 
reinitiation of cell cycling activity by trypsinization and replating as 
described for Fig. 2. Quantitation was performed by direct visuali- 
zation of the nuclear staining activity for statin in 500 cells at various 
time points after  replating as  indicated  by the closed  circles. As 
indicated  here,  ~50%  of  the  cell  culture  had  lost  their  statin 
expression after the  removal of replication-restriction by subcul- 
turing from the high density of 35,550 cells/cm  2 to a low density of 
1,770 cells/cm  2. 
weight doublets were recognized (Fig.  5, lane B). In contrast, 
the antibody did  not react with the protein extracts derived 
from the replicating fibroblasts of the same specimens used 
for the experiments of Fig. 2, G and H  (Fig.  5, lane C). 
Fig. 6 demonstrates the cell cycle distribution and intensity 
of statin expression in nonreplicating flbroblasts of confluent 
cultures,  and  in  the  replicating  flbroblasts that  have  been 
released from the restraint of density arrest by subculturing. 
As shown in A, the majority of cells among the nonreplicating 
fibroblasts, showing positive staining for statin, are the same 
group of cells whose growth is arrested at the Go/G~ phase of 
the cell cycle. This close correlation was lost rapidly when the 
cells were released from the confluent state. The number of 
cells exhibiting positive staining reaction, as well as the fluo- 
rescent intensity of those positive cells,  are significantly re- 
duced (Fig.  6 B). By the analysis of DNA content, fibroblasts 
are distributed in all stages of the cell cycle, including Go/G~, 
S, and G2 phases.  Simultaneous examination of the activity 
of antibody staining shows that regardless of which stage of 
the cell cycle the cells are at, the majority of these replicating 
flbroblasts ofpost-trypsinized cultures contain very little statin 
expression. 
DISCUSSION 
Statin,  a  protein  of 57,000  D,  was initially described to be 
present only in nonreplicating and senescent flbroblasts (l 1). 
Here, I report that the expression ofstatin in young fibroblasts 
of confluent culture can disappear rapidly once the cells are 
released from the environment of density-dependent arrest of 
growth. In cells reentering the cycling process, the disappear- 
ance of a statin-positive phenotype usually precedes the actual 
mitosis.  The  timing  for the  loss  of statin  is  heterogeneous 
among  different  cells.  Our  preliminary  results  of  serum- 
starved nonreplicating cells show that statin is present in them 
too,  and  upon  restoration  of serum  to  the  normal growth 
strength (10%), the expression of statin disappears in the same 
time  scale  as  described  for  wounded  and  post-trypsinized 
FIGURE  4  Localization of statin at the region of the nuclear enve- 
lope in  nonproliferating fibroblasts of confluent cultures of 0011 
cell strain (a). The absence of statin, as seen by the lack of cell- 
bound gold particles, was found in cells whose proliferating  activity 
was reinitiated (b). The exact procedure for the immunogold label- 
ing technique was described  in Materials and Methods. As shown 
in a, most of the gold particles, reflecting the locations of statin, are 
localized at the nuclear envelope region as indicated by the arrow- 
heads. A small proportion of gold particles is found in the nuclear 
matrix region (N). The association of gold particles with the inter- 
mediate filaments on the cytoplasmic side is regarded as nonspe- 
cific, as the same  degree of binding was observed with monoclonal 
antibody to neurofilaments (data not shown). The absence of statin, 
as reflected by the lack of gold particles  at the nuclear envelope 
region,  is apparent in the replicating fibroblasts  (b). Again, a small 
number of gold particles  associated with the cytoskeleton is ob- 
served in this specimen {b). x  100,000. 
cultures (data not shown). 
Analysis by flow cytometry shows that those nonreplicating 
cells showing high statin expression in confluent cultures are 
indeed at the Go/G] stage of the cell cycle. Once cell replica- 
tion is reinitiated, the rapid disappearance of statin is associ- 
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phases of the cell cycle. The advantage of using the technique 
of flow cytometry was appreciated not only for the possibility 
FIGURE 5  Biochemical analysis of the disappearance of statin after 
the reinitiation of cell proliferation. Lane A shows the electropho- 
retie mobility of protein standards at  150, 92, and 58 kD.  Lane B 
shows the presence of a protein at 57,000 D and two high molecular 
weight bands by immunoblotting technique when the statin anti- 
body is incubated with specimens derived from the nonreplicating 
fibroblasts as in Fig. 3 a. The absence of recognizable  protein bands 
is noticed in lane C when the same antibody at the identical IgG 
concentration is incubated with cell extracts from replicating fibro- 
blasts as in Fig. 3 b. The same protein concentration was used for 
gel electrophoresis for both lanes B and C. This was performed by 
applying the same optical density units at 280 to the two gel lanes. 
The efficiency of protein transfer to nitrocellulose paper from the 
two polyacry/amide gel  lanes was controlled by blotting simulta- 
neously in the same run at 150 mA for 12 h at room temperature. 
of simultaneous examination of DNA content and antibody 
staining  for statin,  but  also  for the  ability to  perform the 
survey with large cell samples. 
In post-trypsinized cultures such as those of Fig. 2, G and 
H,  one  can  usually observe 5-10%  of cells  displaying the 
fluorescence positive staining for statin. However, we cannot 
detect the same degree of protein presence with the immu- 
noblotting technique. This difference may result from the fact 
that  specimens  used  for  protein  identifcation  are  pooled 
materials, whereas the microscopic visualization indicates the 
staining activity in single cells. Another possibility could result 
from the difference of sensitivity between immunoperoxidase, 
used for the blotting procedure, and fluorescence used for the 
microscopic studies. 
In the nonreplicating fibroblasts,  statin is primarily located 
at the region of the nuclear envelope. This is different from 
our previous report demonstrating that  the  S-30  antigenic 
activity is present in the entire nuclear region including the 
nuclear envelope (11).  The difference of immunogold local- 
ization may indeed reflect the quantitative difference ofstatin 
expression between  contact-inhibited nonreplicating young 
fibroblasts  and  nonproliferating  senescent  fibroblasts.  We 
have noticed repeatedly that former cells  show less fluores- 
cence  staining  activity than  do  senescent fibroblasts.  This 
quantitative variation is being studied by the technique of 
cytofluorometry,  where a large number of cells (>5,000) from 
different cultures can be readily analyzed. 
Another difference between the nonreplicating young and 
senescent fibroblasts is the mere fact of reversibility for cell 
cycling events in the former but not in the latter (except by 
strenuous means of in vitro cell transformation). We do not 
know whether, assuming the protein is functionally related to 
the traverse of the cell  cycle, there is  a  threshold of statin 
expression determining the irreversibility of replicating ability 
for fibroblasts.  Do the cells at the terminal stage of their life 
span  contain  too  much  statin  to  return to  the  replicative 
pattern? 
Recently, a  few reports have described the presence of a 
protein of 36,000 D  in replicating cells but not in nonrepli- 
eating counterparts (3,  7, 8,  16,  17). The protein, originally 
identified by the sera of some patients with systemic lupus 
erythematosus, detects a  nuclear antigen  of cells  with  high 
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FIGURE 6  Simultaneous  analysis  of  cell 
cycle distribution and  statin expression  by 
flow cytometric studies. (A) Nonreplicating 
fibroblasts of confluent cultures of 0011 cell 
strain at early stage of their life span (cu- 
mulative PDL <  12). (B)  Replicating  fibro- 
blasts of culture with sparse density (3,550/ 
cm2), taken at 24 h after trypsinization and 
replating. The detailed protc.cols for speci- 
men preparation and  manipul:Jtion of flow 
cytometry are described  in  Materials  and 
Methods. The x-axis represents the content 
of DNA, and the y-axis shows the fluores- 
cent staining  intensity for statin.  Each dot 
represents an individual cell measured. The 
measurements below the dashed line were 
considered negative,  as derived  from  the 
background  staining intensity of control ex- 
periments  when  the  primary  antibody to 
statin was replaced by PBS. 
1 700  THE  JOURNAL  OF  CELL  BIOLOGY  .  VOLUME  101,  1985 replicating  activity.  Since  then  a  wide  variety  of cell  types, 
including many permanent cultures of transformed lines, have 
been verified to contain this protein, termed either as prolif- 
erating cell nuclear antigen or cyclin. It is interesting to note 
that, during the cell cycle, the expression of statin is inversely 
related to that of cyclin. We have found through preliminary 
observations  that  the  two  proteins,  statin  and  cyclin,  are 
alternatively  expressed during the transition  from  nonrepli- 
cating to replicating state or vice versa. Most probably, statin 
represents a novel group of proteins present only in cells that 
are  not  proliferating,  whereas  cyclin  is  a  type  of  protein 
expressed only in proliferating cells. 
The most important task now is to understand whether the 
expression  of statin is the cause or the effect associated with 
G0/GI  arrest  of cell  replication.  We  are  attempting  in  vivo 
studies such as microinjection into nonreplicating or replicat- 
ing  cells  with  powerful  probes  such  as  purified  statin,  and 
ultimately the corresponding genes and antibody.  Examina- 
tion of various phenotypes such as mitotic events and DNA 
synthesis in the injected cells may provide promising leads in 
the various functional investigations. 
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